Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk HPV-Negative Head and Neck Cancer from a Phase II Clinical Trial: NRG Oncology RTOG 0234

Added 46 days ago (18.05.2022)
Authors: Chieko Michikawa, Pedro A. Torres-Saavedra, Natalie L. Silver, Paul M. Harari, Merrill S. Kies, David I. Rosenthal, Quynh-Thu Le, Richard C. Jordan, Dzifa Y. Duose, Saradhi Mallampati, Sanchit Trivedi, Rajyalakshmi Luthra, Ignacio I. Wistuba, Abdullah A. Osman, Olivier Lichtarge, Robert L. Foote, Upendra Parvathaneni, D. Neil Hayes, Curtis R. Pickering, Jeffrey N. Myers
Read article